Ultrasonic Garment With Variable Intensity for Non-Invasive Cell Control

The patent replaces the mechanical compression and manual examination system of traditional mammography with an ultrasonic wave-based detection system. The ultrasonic transducers emit sound waves that penetrate tissue without mechanical contact, eliminating the pain and discomfort associated with compression while maintaining detection capability through acoustic imaging.

The patent introduces ultrasonic waves as an intermediary medium between the detection device and the tissue. These waves serve as a non-invasive carrier of information about internal tissue structures, allowing detection without direct mechanical contact or compression that causes pain in traditional mammography.

The patent changes the fundamental parameter of treatment from chemical dosage to physical energy intensity. By using ultrasonic waves with adjustable intensity levels, the system can deliver targeted thermal and mechanical effects to cancer cells without introducing chemical substances that cause systemic side effects, thereby maintaining treatment effectiveness while eliminating harmful side effects.

The patent applies ultrasonic energy locally to the cancerous tissue through targeted transducer placement. The energy is concentrated at the treatment site through focused ultrasound beams, producing localized thermal and mechanical effects that destroy cancer cells while leaving surrounding healthy tissue unaffected, thus avoiding the systemic side effects of high-dose chemotherapy.

The patent replaces invasive mechanical surgical intervention with non-contact ultrasonic energy delivery. The ultrasonic transducers emit sound waves that penetrate tissue and produce therapeutic effects through acoustic pressure and thermal heating, eliminating the need for incisions, anesthesia, and surgical recovery while maintaining cancer elimination capability.

The patent uses ultrasonic waves as an intermediary that delivers therapeutic energy without direct physical invasion. The waves transmit mechanical and thermal energy through tissue to the cancer target, achieving treatment without surgical instruments, needles, or other invasive devices that compromise patient comfort.

The patent employs periodic pulsed ultrasound delivery with alternating treatment and rest periods. The ultrasonic energy is delivered in controlled bursts followed by intervals that allow normal tissue recovery and heat dissipation, enabling cumulative therapeutic effect on cancer cells while preventing excessive thermal damage to surrounding healthy tissue.

The patent implements dynamic adjustment of ultrasonic intensity parameters during treatment. The system continuously monitors tissue response and adapts the acoustic power, pulse duration, and duty cycle in real-time, increasing intensity when cancer cells are targeted while reducing it when normal tissue is encountered, thereby maximizing therapeutic effect while minimizing damage.